Created On: 2020-07-15
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 5999
The CellScan is a technology designed for the viewing and testing of cells. The CellScan was originally developed to diagnose breast cancer by testing a patientâ€™s blood sample. Various medical and research institutions in Israel, the United States and other countries are exploring the use of the technology for the detection of breast cancer, prostate cancer and gynecological cancers, and for the detection of other diseases such as atherosclerosis and tuberculosis. In addition, an advanced version of the CellScan called the research CellScan has been developed which, we believe, has research applications in a number of areas including gene therapy and drug and vaccine development.
IPSCIO Record ID: 28119
The system includes the instrument known as the Cellscan, including all or part of its derivatives and components as well the testing kits used by the Cellscan for performing blood tests for the purpose of diagnosing malignant diseases, their classification and repeat testing at the level of the individual cell at the time of its exposure to a series of manipulations, as well as their derivatives, which were and will be developed in the course of development of the Cellscan system.
The system also includes assemblies bearing blood cells, technology, mechanical and dynamic components, light sources, optical components, electronic components including a computer used as controller of the tests analyzing their results in real time, all of which are integrated in the system. It also includes irritants, by-products and exhaustible support materials needed for the tests, which were and will be development in the course of research and development of the Cellscan system, for the purpose of their use in the system.
The Desktop CellScan is a state of the art cytometer that can repeatedly and continuously monitor the fluorescence intensity and polarization of individual, non-adherent living cells. This system substantially extends the range and enhances the capabilities of other cytometric measuring devices, including earlier CellScan models. We expect to produce the Desktop CellScan at a lower cost than the earlier CellScan models. As before, the heart of the CellScan is a unique, patented cell carrier that contains up to 10,000 wells, each of which can accommodate a single cell. The capacity to precisely and faithfully measure optical parameters of individual living cells greatly facilitates kinetic analyses of individual cells within a heterogeneous cell populations, which is particularly useful for investigating physiological, clinical and diagnostic aspects of cells.
IPSCIO Record ID: 26074
An exclusive worldwide right and license to use the Know-How and the Tooling and Test Equipment to Manufacture, Sell, and Support the Licensed product;
A non-exclusive worldwide right and license to use the Know-How and the Tooling and Test Equipment in the design and development of improvements to the Licensed product; and
An exclusive worldwide right and license to use the Know-How and Tooling and Test Equipment to design, Manufacture, Sell and Support any derivative of the Licensed which has a blood-related medical application or use.
The CellScan system is a detection and monitoring system for human cells which may have many potential applications relating to disease diagnostics and determining chemosensitivity.
IPSCIO Record ID: 26038
Fieldâ€ shall mean in vitro diagnostics for screening, diagnosing and monitoring for Ovarian Cancer in humans in the form of OVA1 tests.